CVS Health EBITDA 2010-2024 | CVS

CVS Health EBITDA for the quarter ending September 30, 2024 was $1.993B, a 58.63% decline year-over-year.

  • CVS Health 2023 EBITDA was 18.109B, a 48.7% increase from 2022.
  • CVS Health 2022 EBITDA was 12.178B, a 33.19% decline from 2021.
  • CVS Health 2021 EBITDA was 18.227B, a 0.68% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

CVS Health EBITDA 2010-2024 | CVS

  • CVS Health 2023 EBITDA was 18.109B, a 48.7% increase from 2022.
  • CVS Health 2022 EBITDA was 12.178B, a 33.19% decline from 2021.
  • CVS Health 2021 EBITDA was 18.227B, a 0.68% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Walgreens (WBA)$7.2B
Herbalife (HLF)$778M
China Jo-Jo Drugstores Holdings (CJJD)$14M
GNC Holdings (GNC)$0M